- Home
- OGI vs ENTA Comparison
OGI vs ENTA Comparison
Compare OGI & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- ENTA
- Stock Information
- Founded
- OGI 2013
- ENTA 1995
- Country
- OGI Canada
- ENTA United States
- Employees
- OGI N/A
- ENTA N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- OGI Health Care
- ENTA Health Care
- Exchange
- OGI Nasdaq
- ENTA Nasdaq
- Market Cap
- OGI 155.2M
- ENTA 154.0M
- IPO Year
- OGI N/A
- ENTA 2013
- Fundamental
- Price
- OGI $1.18
- ENTA $5.27
- Analyst Decision
- OGI
- ENTA Buy
- Analyst Count
- OGI 0
- ENTA 4
- Target Price
- OGI N/A
- ENTA $17.25
- AVG Volume (30 Days)
- OGI 382.1K
- ENTA 194.0K
- Earning Date
- OGI 05-12-2025
- ENTA 05-20-2025
- Dividend Yield
- OGI N/A
- ENTA N/A
- EPS Growth
- OGI N/A
- ENTA N/A
- EPS
- OGI N/A
- ENTA N/A
- Revenue
- OGI $115,451,336.00
- ENTA $66,590,999.00
- Revenue This Year
- OGI $50.30
- ENTA N/A
- Revenue Next Year
- OGI $16.01
- ENTA N/A
- P/E Ratio
- OGI N/A
- ENTA N/A
- Revenue Growth
- OGI N/A
- ENTA N/A
- 52 Week Low
- OGI $0.85
- ENTA $4.09
- 52 Week High
- OGI $2.11
- ENTA $17.24
- Technical
- Relative Strength Index (RSI)
- OGI 60.23
- ENTA 45.38
- Support Level
- OGI $1.09
- ENTA $4.96
- Resistance Level
- OGI $1.20
- ENTA $6.23
- Average True Range (ATR)
- OGI 0.06
- ENTA 0.33
- MACD
- OGI 0.01
- ENTA -0.01
- Stochastic Oscillator
- OGI 88.24
- ENTA 24.41
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.